We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (376)
- Scheduling (national classification system) (174)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Sunscreens (5)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
764 result(s) found, displaying 526 to 550
-
Meeting statementsACM 12 meeting statement has been published
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 7 March 2019
-
Corporate reportsAlkyl nitrites public meeting questions and answers are now available
-
Scheduling submissionsThe TGA would like to thank respondents who provided submissions in response to the November 2018 public consultation paper
-
Meeting statementsACCM meeting statement for 16 November 2018 published
-
Corporate reportsReport providing a summary of findings from the 2018 Therapeutic Goods Administration stakeholder survey
-
Corporate reportsThe TGA conducted a survey of Australian adults in June and July 2018
-
Corporate reports2018 TGA stakeholder survey reports available
-
Corporate reportsThe TGA has published its Self-Assessment Report for 2017-18
-
Scheduling submissionsPublic submissions on the delegate's interim decisions
-
Scheduling decisions (final)Delegate only final scheduling decisions on NCEs and Appendix H are now available
-
Scheduling decisions (final)Final decisions and reasons for medicines and chemicals referred to the June 2018 scheduling meetings (ACMS #24 and Joint ACMS-ACCS #19) and delegate-only decisions on agricultural and veterinary chemicals.
-
Meeting statementsThe Advisory Committee on Medicines meeting statement for Meeting 11 is now available
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting 43 statement.
-
Corporate reportsOverview of what we have done in response to comments in the 2017 TGA stakeholder survey.
-
Corporate reportsARGMD landing page updated with links to new guidance.
-
Corporate reportsThe Australian Government response to the Mesh Senate inquiry has been published.
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 11 statement
-
Scheduling decisions (final)Revised final decisions for matters referred to the March 2018 ACMS/ACCS meetings and delegate-only decisions on agricultural chemicals and NCEs.
-
Corporate reportsDetailed statistical information on our performance
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting 42 statement.
-
Corporate reportsInternational engagement: how TGA collaborates to share learnings, align policies, standards and regulatory processes
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 October 2018
-
Meeting statementsThe Advisory Committee on Medicines meeting statement is now available